Nicoletta Colombo, MD, PhD, of the University of Milan-Bicocca, discussed the rationale behind paclitaxel with bevacizumab ...

Individuals diagnosed with chronic spontaneous urticaria (CSU) are at a moderately increased risk of multiple cardiovascular ...

Online health discussions can influence patient behaviors, but misinformation spreads easily. Khush Kharidia, MD, UT Southwestern, explains how creator credibility impacts cholesterol-related health ...

Jo Varshney, PhD, DVM, discusses how artificial intelligence–powered simulations speed drug approvals and reduce clinical ...

When families come into the clinic, there is a lot of hand-holding, Spizuoco said, to explain the treatments. She recommends ...

Outbreaks of measles have been seeing an uptick in 2025, which, according to a new review, 1 leads to financial and public health strain in the US. Researchers recommend widespread use of measles ...

Both children and adults can injure their eyes through a bad fall or getting hit in the eye, making awareness of surroundings ...

By collaborating with patients from the very start and respecting their unique perspectives, decision-makers can create a ...

Access to glucagon-like peptide-1 (GLP-1) receptor agonists for obesity treatment could be expanded through innovative ...

A new study 1 found that the use of stereotactic body radiation therapy (SBRT) produced similar overall survival in patients ...

Rocatinlimab shows real-world promise for moderate to severe AD, enhancing treatment efficacy and reducing steroid reliance, explains Emma Guttman-Yassky, MD, PhD.

Changing the FDA biosimilar interchangeability standards is a necessary but likely insufficient step to improve biosimilar competition in the US.